These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 34169640)

  • 21. Sgemaglutide in type 2 diabetes - is it the best glucagon-like peptide 1 receptor agonist (GLP-1R agonist)?
    Doggrell SA
    Expert Opin Drug Metab Toxicol; 2018 Mar; 14(3):371-377. PubMed ID: 29439603
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Profile of semaglutide in the management of type 2 diabetes: design, development, and place in therapy.
    Gomez-Peralta F; Abreu C
    Drug Des Devel Ther; 2019; 13():731-738. PubMed ID: 30863012
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Meal sequence and glucose excursion, gastric emptying and incretin secretion in type 2 diabetes: a randomised, controlled crossover, exploratory trial.
    Kuwata H; Iwasaki M; Shimizu S; Minami K; Maeda H; Seino S; Nakada K; Nosaka C; Murotani K; Kurose T; Seino Y; Yabe D
    Diabetologia; 2016 Mar; 59(3):453-61. PubMed ID: 26704625
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of exenatide versus sitagliptin on postprandial glucose, insulin and glucagon secretion, gastric emptying, and caloric intake: a randomized, cross-over study.
    DeFronzo RA; Okerson T; Viswanathan P; Guan X; Holcombe JH; MacConell L
    Curr Med Res Opin; 2008 Oct; 24(10):2943-52. PubMed ID: 18786299
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of lipase inhibition on gastric emptying of, and the glycemic and incretin responses to, an oil/aqueous drink in type 2 diabetes mellitus.
    Pilichiewicz A; O'Donovan D; Feinle C; Lei Y; Wishart JM; Bryant L; Meyer JH; Horowitz M; Jones KL
    J Clin Endocrinol Metab; 2003 Aug; 88(8):3829-34. PubMed ID: 12915676
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of sequential treatment with lixisenatide, insulin glargine, or their combination on meal-related glycaemic excursions, insulin and glucagon secretion, and gastric emptying in patients with type 2 diabetes.
    Meier JJ; Menge BA; Schenker N; Erdmann S; Kahle-Stephan M; Schliess F; Kapitza C; Nauck MA
    Diabetes Obes Metab; 2020 Apr; 22(4):599-611. PubMed ID: 31793165
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glucagon-like peptide 2 stimulates glucagon secretion, enhances lipid absorption, and inhibits gastric acid secretion in humans.
    Meier JJ; Nauck MA; Pott A; Heinze K; Goetze O; Bulut K; Schmidt WE; Gallwitz B; Holst JJ
    Gastroenterology; 2006 Jan; 130(1):44-54. PubMed ID: 16401467
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Title: Differentiating the effects of whey protein and guar gum preloads on postprandial glycemia in type 2 diabetes.
    Watson LE; Phillips LK; Wu T; Bound MJ; Checklin H; Grivell J; Jones KL; Horowitz M; Rayner CK
    Clin Nutr; 2019 Dec; 38(6):2827-2832. PubMed ID: 30583967
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lixisenatide reduces postprandial hyperglycaemia via gastrostatic and insulinotropic effects.
    Becker RH; Stechl J; Steinstraesser A; Golor G; Pellissier F
    Diabetes Metab Res Rev; 2015 Sep; 31(6):610-8. PubMed ID: 25773712
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Postdinner resistance exercise improves postprandial risk factors more effectively than predinner resistance exercise in patients with type 2 diabetes.
    Heden TD; Winn NC; Mari A; Booth FW; Rector RS; Thyfault JP; Kanaley JA
    J Appl Physiol (1985); 2015 Mar; 118(5):624-34. PubMed ID: 25539939
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of starvation and short-term refeeding on gastric emptying and postprandial blood glucose regulation in adolescent girls with anorexia nervosa.
    Heruc GA; Little TJ; Kohn MR; Madden S; Clarke SD; Horowitz M; Feinle-Bisset C
    Am J Physiol Endocrinol Metab; 2018 Oct; 315(4):E565-E573. PubMed ID: 29969316
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative Effects of the Branched-Chain Amino Acids, Leucine, Isoleucine and Valine, on Gastric Emptying, Plasma Glucose, C-Peptide and Glucagon in Healthy Men.
    Elovaris RA; Bitarafan V; Agah S; Ullrich SS; Lange K; Horowitz M; Feinle-Bisset C
    Nutrients; 2021 May; 13(5):. PubMed ID: 34064996
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanism of accelerated gastric emptying of liquids and hyperglycemia in patients with type II diabetes mellitus.
    Frank JW; Saslow SB; Camilleri M; Thomforde GM; Dinneen S; Rizza RA
    Gastroenterology; 1995 Sep; 109(3):755-65. PubMed ID: 7657103
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hormonal Responses to Cholinergic Input Are Different in Humans with and without Type 2 Diabetes Mellitus.
    Chowdhury S; Wang S; Dunai J; Kilpatrick R; Oestricker LZ; Wallendorf MJ; Patterson BW; Reeds DN; Wice BM
    PLoS One; 2016; 11(6):e0156852. PubMed ID: 27304975
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A role for pancreatic polypeptide in the regulation of gastric emptying and short-term metabolic control.
    Schmidt PT; Näslund E; Grybäck P; Jacobsson H; Holst JJ; Hilsted L; Hellström PM
    J Clin Endocrinol Metab; 2005 Sep; 90(9):5241-6. PubMed ID: 15998783
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeting postprandial glycaemia in children with diabetes: Opportunities and challenges.
    Geyer MC; Rayner CK; Horowitz M; Couper JJ
    Diabetes Obes Metab; 2018 Apr; 20(4):766-774. PubMed ID: 29072820
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of gastric emptying.
    Young A
    Adv Pharmacol; 2005; 52():99-121. PubMed ID: 16492543
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of GLP-1 and Its Analogs on Gastric Physiology in Diabetes Mellitus and Obesity.
    Maselli DB; Camilleri M
    Adv Exp Med Biol; 2021; 1307():171-192. PubMed ID: 32077010
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of dipeptidyl peptidase-4 inhibition on gastrointestinal function, meal appearance, and glucose metabolism in type 2 diabetes.
    Vella A; Bock G; Giesler PD; Burton DB; Serra DB; Saylan ML; Dunning BE; Foley JE; Rizza RA; Camilleri M
    Diabetes; 2007 May; 56(5):1475-80. PubMed ID: 17303799
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics, pharmacodynamics, and safety of exenatide in patients with type 2 diabetes mellitus.
    Kolterman OG; Kim DD; Shen L; Ruggles JA; Nielsen LL; Fineman MS; Baron AD
    Am J Health Syst Pharm; 2005 Jan; 62(2):173-81. PubMed ID: 15700891
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.